Rebecca Runyan Dowdy, NP
Women's Health · Houston, TXNPI 1336218981
Payments from drug & device makers
Across 57 payments — averaging $28.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Women's Health, Inc.$315
- AbbVie$211
- Astellas Pharma US Inc$145
- GSK$120
- Bayer$113
- Otsuka America Pharmaceutical, Inc.$91
- plus $617 from 20 others
What the payments were for
- Food & beverage$1,612100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Women's Health, Inc. | 1 | $315 |
| AbbVie | 14 | $211 |
| Astellas Pharma US Inc | 2 | $145 |
| GSK | 1 | $120 |
| Bayer | 5 | $113 |
| Otsuka America Pharmaceutical, Inc. | 1 | $91 |
| Sumitomo Pharma America, Inc. | 5 | $85 |
| Shield Therapeutics Inc | 4 | $66 |
| Myovant Sciences Inc. | 2 | $51 |
| Mayne Pharma Commercial LLC | 2 | $42 |
| Organon | 2 | $39 |
| Exeltis, USA Inc. | 2 | $37 |
| Evofem Biosciences, Inc. | 2 | $36 |
| Therapeuticsmd, Inc. | 2 | $34 |
| Medtronic | 1 | $33 |
| Biogen | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Aspira Women's Health Inc | 1 | $21 |
| Exact Sciences | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Merck | 1 | $17 |
| Davol Inc. | 1 | $17 |
| Agile Therapeutics, Inc. | 1 | $16 |
| Ascend Therapeutics US, LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Avion Pharmaceuticals | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,612 in reported general payments places this provider in the 85th percentile of 609 women's health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 144 | $12,499 |
| Estradiol (Twice Weekly)Estradiol | 83 | $9,081 |
| YuvafemEstradiol | 16 | $2,965 |
| LyllanaEstradiol | 12 | $1,595 |
| ProgesteroneProgesterone, Micronized | 50 | $1,271 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 12 | $1,268 |
| Raloxifene Hcl | 12 | $377 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 19 | $361 |
| Fluconazole | 19 | $97 |
Paid to pharmacies, not to this prescriber.
Other women's health in Houston
- Joann St PierreHouston$15K
- Lori WinkHouston$9K
- Andrea DunnHouston$6K
- Kim GustafsonHouston$4K
- Erica SmithHouston$4K
- Christie LouisHouston$3K
- Mary UmbleHouston$3K
- Kim OkewunmiHouston$3K
- Kathryn AckermanHouston$2K
- Evelyn TingGrapevine$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.